{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T00:46:01Z","timestamp":1771461961589,"version":"3.50.1"},"reference-count":43,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2014,6,4]],"date-time":"2014-06-04T00:00:00Z","timestamp":1401840000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Diabetologia"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1007\/s00125-014-3278-9","type":"journal-article","created":{"date-parts":[[2014,6,3]],"date-time":"2014-06-03T16:50:06Z","timestamp":1401814206000},"page":"1842-1849","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Circulating peroxiredoxin 4 and type 2 diabetes risk: the Prevention of Renal and Vascular Endstage Disease (PREVEND) study"],"prefix":"10.1007","volume":"57","author":[{"given":"Ali","family":"Abbasi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eva","family":"Corpeleijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron T.","family":"Gansevoort","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rijk O. B.","family":"Gans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joachim","family":"Struck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janin","family":"Schulte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hans L.","family":"Hillege","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pim","family":"van der Harst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronald P.","family":"Stolk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerjan","family":"Navis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan J. L.","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2014,6,4]]},"reference":[{"key":"3278_CR1","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","volume":"364","author":"SR Seshasai","year":"2011","unstructured":"Seshasai SR, Kaptoge S, Thompson A et al (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364:829\u2013841","journal-title":"N Engl J Med"},{"key":"3278_CR2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(11)60679-X","volume":"378","author":"G Danaei","year":"2011","unstructured":"Danaei G, Finucane MM, Lu Y et al (2011) National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2.7 million participants. Lancet 378:31\u201340","journal-title":"Lancet"},{"key":"3278_CR3","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1172\/JCI200525102","volume":"115","author":"KE Wellen","year":"2005","unstructured":"Wellen KE, Hotamisligil GS (2005) Inflammation, stress, and diabetes. J Clin Invest 115:1111\u20131119","journal-title":"J Clin Invest"},{"key":"3278_CR4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3109\/10408360903142326","volume":"46","author":"D Giustarini","year":"2009","unstructured":"Giustarini D, Dalle-Donne I, Tsikas D, Rossi R (2009) Oxidative stress and human diseases: origin, link, measurement, mechanisms, and biomarkers. Crit Rev Clin Lab Sci 46:241\u2013281","journal-title":"Crit Rev Clin Lab Sci"},{"key":"3278_CR5","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1093\/aje\/kwt002","volume":"178","author":"K Matsushita","year":"2012","unstructured":"Matsushita K, Williams EK, Mongraw-Chaffin ML et al (2012) The association of plasma lactate with incident cardiovascular outcomes: the ARIC study. Am J Epidemiol 178:401\u2013409","journal-title":"Am J Epidemiol"},{"key":"3278_CR6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1373\/clinchem.2005.061408","volume":"52","author":"I Dalle-Donne","year":"2006","unstructured":"Dalle-Donne I, Rossi R, Colombo R, Giustarini D, Milzani A (2006) Biomarkers of oxidative damage in human disease. Clin Chem 52:601\u2013623","journal-title":"Clin Chem"},{"key":"3278_CR7","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.ijcard.2010.08.008","volume":"147","author":"NA Strobel","year":"2011","unstructured":"Strobel NA, Fassett RG, Marsh SA, Coombes JS (2011) Oxidative stress biomarkers as predictors of cardiovascular disease. Int J Cardiol 147:191\u2013201","journal-title":"Int J Cardiol"},{"key":"3278_CR8","doi-asserted-by":"crossref","unstructured":"Melander O, Newton-Cheh C, Almgren P et al (2009) Novel and conventional biomarkers for prediction of incident cardiovascular events in the community. JAMA 302:49\u201357","DOI":"10.1001\/jama.2009.943"},{"key":"3278_CR9","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1089\/ars.2012.4946","volume":"19","author":"A Nabeshima","year":"2013","unstructured":"Nabeshima A, Yamada S, Guo X et al (2013) Peroxiredoxin 4 protects against nonalcoholic steatohepatitis and type 2 diabetes in a nongenetic mouse model. Antioxid Redox Signal 19:1983\u20131998","journal-title":"Antioxid Redox Signal"},{"key":"3278_CR10","doi-asserted-by":"crossref","first-page":"4927","DOI":"10.1002\/pmic.200500050","volume":"5","author":"S Barcelo-Batllori","year":"2005","unstructured":"Barcelo-Batllori S, Corominola H, Claret M, Canals I, Guinovart J, Gomis R (2005) Target identification of the novel antiobesity agent tungstate in adipose tissue from obese rats. Proteomics 5:4927\u20134935","journal-title":"Proteomics"},{"key":"3278_CR11","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1089\/ars.2010.3137","volume":"13","author":"Y Ding","year":"2010","unstructured":"Ding Y, Yamada S, Wang KY et al (2010) Overexpression of peroxiredoxin 4 protects against high-dose streptozotocin-induced diabetes by suppressing oxidative stress and cytokines in transgenic mice. Antioxid Redox Signal 13:1477\u20131490","journal-title":"Antioxid Redox Signal"},{"key":"3278_CR12","doi-asserted-by":"crossref","first-page":"7004","DOI":"10.1073\/pnas.1013012108","volume":"108","author":"Q Wei","year":"2011","unstructured":"Wei Q, Jiang H, Xiao Z et al (2011) Sulfiredoxin-Peroxiredoxin IV axis promotes human lung cancer progression through modulation of specific phosphokinase signaling. Proc Natl Acad Sci U S A 108:7004\u20137009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"3278_CR13","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1093\/oxfordjournals.jbchem.a022632","volume":"127","author":"A Okado-Matsumoto","year":"2000","unstructured":"Okado-Matsumoto A, Matsumoto A, Fujii J, Taniguchi N (2000) Peroxiredoxin IV is a secretable protein with heparin-binding properties under reduced conditions. J Biochem 127:493\u2013501","journal-title":"J Biochem"},{"key":"3278_CR14","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1016\/j.cca.2010.05.016","volume":"411","author":"J Schulte","year":"2010","unstructured":"Schulte J, Struck J, Bergmann A, Kohrle J (2010) Immunoluminometric assay for quantification of peroxiredoxin 4 in human serum. Clin Chim Acta 411:1258\u20131263","journal-title":"Clin Chim Acta"},{"key":"3278_CR15","doi-asserted-by":"crossref","first-page":"e002956","DOI":"10.1161\/JAHA.112.002956","volume":"1","author":"A Abbasi","year":"2012","unstructured":"Abbasi A, Corpeleijn E, Postmus D et al (2012) Peroxiredoxin 4, a novel circulating biomarker for oxidative stress and the risk of incident cardiovascular disease and all-cause mortality. J Am Heart Assoc 1:e002956","journal-title":"J Am Heart Assoc"},{"key":"3278_CR16","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/SHK.0b013e3182115f40","volume":"35","author":"J Schulte","year":"2011","unstructured":"Schulte J, Struck J, Kohrle J, Muller B (2011) Circulating levels of peroxiredoxin 4 as a novel biomarker of oxidative stress in patients with sepsis. Shock 35:460\u2013465","journal-title":"Shock"},{"key":"3278_CR17","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1093\/aje\/kwn209","volume":"168","author":"HJ Lambers Heerspink","year":"2008","unstructured":"Lambers Heerspink HJ, Brantsma AH, de Zeeuw D, Bakker SJ, de Jong PE, Gansevoort RT (2008) Albuminuria assessed from first-morning-void urine samples versus 24-hour urine collections as a predictor of cardiovascular morbidity and mortality. Am J Epidemiol 168:897\u2013905","journal-title":"Am J Epidemiol"},{"key":"3278_CR18","doi-asserted-by":"crossref","unstructured":"Mahmoodi BK, Gansevoort RT, Veeger NJ et al (2009) Microalbuminuria and risk of venous thromboembolism. JAMA 301:1790\u20131797","DOI":"10.1001\/jama.2009.565"},{"key":"3278_CR19","doi-asserted-by":"crossref","first-page":"E26","DOI":"10.1210\/jc.2010-0305","volume":"95","author":"A Abbasi","year":"2010","unstructured":"Abbasi A, Corpeleijn E, Postmus D et al (2010) Plasma procalcitonin is associated with obesity, insulin resistance, and the metabolic syndrome. J Clin Endocrinol Metab 95:E26\u2013E31","journal-title":"J Clin Endocrinol Metab"},{"key":"3278_CR20","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1007\/s00125-011-2216-3","volume":"54","author":"A Abbasi","year":"2011","unstructured":"Abbasi A, Corpeleijn E, Postmus D et al (2011) Plasma procalcitonin and risk of type 2 diabetes in the general population. Diabetologia 54:2463\u20132465","journal-title":"Diabetologia"},{"key":"3278_CR21","doi-asserted-by":"crossref","first-page":"d7163","DOI":"10.1136\/bmj.d7163","volume":"343","author":"D Noble","year":"2011","unstructured":"Noble D, Mathur R, Dent T, Meads C, Greenhalgh T (2011) Risk models and scores for type 2 diabetes: systematic review. BMJ 343:d7163","journal-title":"BMJ"},{"key":"3278_CR22","doi-asserted-by":"crossref","first-page":"e5900","DOI":"10.1136\/bmj.e5900","volume":"345","author":"A Abbasi","year":"2012","unstructured":"Abbasi A, Peelen LM, Corpeleijn E et al (2012) Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study. BMJ 345:e5900","journal-title":"BMJ"},{"key":"3278_CR23","doi-asserted-by":"crossref","first-page":"3320","DOI":"10.2337\/diacare.26.12.3320","volume":"26","author":"JF Ascaso","year":"2003","unstructured":"Ascaso JF, Pardo S, Real JT, Lorente RI, Priego A, Carmena R (2003) Diagnosing insulin resistance by simple quantitative methods in subjects with normal glucose metabolism. Diabetes Care 26:3320\u20133325","journal-title":"Diabetes Care"},{"key":"3278_CR24","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s00125-011-2067-y","volume":"54","author":"MF Hivert","year":"2011","unstructured":"Hivert MF, Sullivan LM, Shrader P et al (2011) Insulin resistance influences the association of adiponectin levels with diabetes incidence in two population-based cohorts: the Cooperative Health Research in the Region of Augsburg (KORA) S4\/F4 study and the Framingham Offspring Study. Diabetologia 54:1019\u20131024","journal-title":"Diabetologia"},{"key":"3278_CR25","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0197-2456(86)90034-6","volume":"7","author":"JL Fleiss","year":"1986","unstructured":"Fleiss JL (1986) Analysis of data from multiclinic trials. Control Clin Trials 7:267\u2013275","journal-title":"Control Clin Trials"},{"key":"3278_CR26","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.2337\/dc08-0368","volume":"31","author":"B Balkau","year":"2008","unstructured":"Balkau B, Lange C, Fezeu L et al (2008) Predicting diabetes: clinical, biological, and genetic approaches: data from the Epidemiological Study on the Insulin Resistance Syndrome (DESIR). Diabetes Care 31:2056\u20132061","journal-title":"Diabetes Care"},{"key":"3278_CR27","doi-asserted-by":"crossref","first-page":"1712","DOI":"10.1001\/archinternmed.2011.351","volume":"171","author":"NP Paynter","year":"2011","unstructured":"Paynter NP, Mazer NA, Pradhan AD, Gaziano JM, Ridker PM, Cook NR (2011) Cardiovascular risk prediction in diabetic men and women using hemoglobin A1c vs diabetes as a high-risk equivalent. Arch Intern Med 171:1712\u20131718","journal-title":"Arch Intern Med"},{"key":"3278_CR28","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/sim.4085","volume":"30","author":"MJ Pencina","year":"2011","unstructured":"Pencina MJ, D\u2019Agostino RB Sr, Steyerberg EW (2011) Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers. Stat Med 30:11\u201321","journal-title":"Stat Med"},{"key":"3278_CR29","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S1047-2797(97)00107-5","volume":"8","author":"MW Knuiman","year":"1998","unstructured":"Knuiman MW, Divitini ML, Buzas JS, Fitzgerald PE (1998) Adjustment for regression dilution in epidemiological regression analyses. Ann Epidemiol 8:56\u201363","journal-title":"Ann Epidemiol"},{"key":"3278_CR30","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1001\/archinte.167.10.1068","volume":"167","author":"PW Wilson","year":"2007","unstructured":"Wilson PW, Meigs JB, Sullivan L, Fox CS, Nathan DM, D\u2019Agostino RB Sr (2007) Prediction of incident diabetes mellitus in middle-aged adults: the Framingham Offspring Study. Arch Intern Med 167:1068\u20131074","journal-title":"Arch Intern Med"},{"key":"3278_CR31","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s12192-013-0442-y","volume":"19","author":"E Eter El","year":"2014","unstructured":"El Eter E, Al Masri A, Habib S et al (2014) Novel links among peroxiredoxins, endothelial dysfunction, and severity of atherosclerosis in type 2 diabetic patients with peripheral atherosclerotic disease. Cell Stress Chaperones 19:173\u2013181","journal-title":"Cell Stress Chaperones"},{"key":"3278_CR32","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/s00125-009-1576-4","volume":"53","author":"T Dreja","year":"2010","unstructured":"Dreja T, Jovanovic Z, Rasche A et al (2010) Diet-induced gene expression of isolated pancreatic islets from a polygenic mouse model of the metabolic syndrome. Diabetologia 53:309\u2013320","journal-title":"Diabetologia"},{"key":"3278_CR33","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1038\/nature04634","volume":"440","author":"N Houstis","year":"2006","unstructured":"Houstis N, Rosen ED, Lander ES (2006) Reactive oxygen species have a causal role in multiple forms of insulin resistance. Nature 440:944\u2013948","journal-title":"Nature"},{"key":"3278_CR34","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S0968-0004(02)00003-8","volume":"28","author":"ZA Wood","year":"2003","unstructured":"Wood ZA, Schroder E, Robin Harris J, Poole LB (2003) Structure, mechanism and regulation of peroxiredoxins. Trends Biochem Sci 28:32\u201340","journal-title":"Trends Biochem Sci"},{"key":"3278_CR35","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1111\/j.1553-2712.2011.01126.x","volume":"18","author":"CH Nickel","year":"2011","unstructured":"Nickel CH, Ruedinger J, Misch F et al (2011) Copeptin and peroxiredoxin-4 independently predict mortality in patients with nonspecific complaints presenting to the emergency department. Acad Emerg Med 18:851\u2013859","journal-title":"Acad Emerg Med"},{"key":"3278_CR36","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.CIR.0000031732.78052.81","volume":"106","author":"HL Hillege","year":"2002","unstructured":"Hillege HL, Fidler V, Diercks GF et al (2002) Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population. Circulation 106:1777\u20131782","journal-title":"Circulation"},{"key":"3278_CR37","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(11)60105-0","volume":"377","author":"D Wormser","year":"2011","unstructured":"Wormser D, Kaptoge S, Di Angelantonio E et al (2011) Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies. Lancet 377:1085\u20131095","journal-title":"Lancet"},{"key":"3278_CR38","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1186\/1741-7015-9-137","volume":"9","author":"J Schulte","year":"2011","unstructured":"Schulte J (2011) Peroxiredoxin 4: a multifunctional biomarker worthy of further exploration. BMC Med 9:137","journal-title":"BMC Med"},{"key":"3278_CR39","doi-asserted-by":"crossref","first-page":"30952","DOI":"10.1074\/jbc.272.49.30952","volume":"272","author":"DY Jin","year":"1997","unstructured":"Jin DY, Chae HZ, Rhee SG, Jeang KT (1997) Regulatory role for a novel human thioredoxin peroxidase in NF-kappaB activation. J Biol Chem 272:30952\u201330961","journal-title":"J Biol Chem"},{"key":"3278_CR40","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1089\/15230860050192288","volume":"2","author":"CM Wong","year":"2000","unstructured":"Wong CM, Chun AC, Kok KH et al (2000) Characterization of human and mouse peroxiredoxin IV: evidence for inhibition by Prx-IV of epidermal growth factor- and p53-induced reactive oxygen species. Antioxid Redox Signal 2:507\u2013518","journal-title":"Antioxid Redox Signal"},{"key":"3278_CR41","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.1016\/j.febslet.2007.07.011","volume":"581","author":"P Giguere","year":"2007","unstructured":"Giguere P, Turcotte ME, Hamelin E et al (2007) Peroxiredoxin-4 interacts with and regulates the thromboxane A(2) receptor. FEBS Lett 581:3863\u20133868","journal-title":"FEBS Lett"},{"key":"3278_CR42","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1089\/ars.2009.3079","volume":"13","author":"M Bertolotti","year":"2010","unstructured":"Bertolotti M, Yim SH, Garcia-Manteiga JM et al (2010) B- to plasma-cell terminal differentiation entails oxidative stress and profound reshaping of the antioxidant responses. Antioxid Redox Signal 13:1133\u20131144","journal-title":"Antioxid Redox Signal"},{"key":"3278_CR43","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1056\/NEJMoa1105351","volume":"365","author":"PE Pergola","year":"2011","unstructured":"Pergola PE, Raskin P, Toto RD et al (2011) Bardoxolone methyl and kidney function in CKD with type 2 diabetes. N Engl J Med 365:327\u2013336","journal-title":"N Engl J Med"}],"container-title":["Diabetologia"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00125-014-3278-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-014-3278-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00125-014-3278-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,2,26]],"date-time":"2019-02-26T19:11:59Z","timestamp":1551208319000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00125-014-3278-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,6,4]]},"references-count":43,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["3278"],"URL":"https:\/\/doi.org\/10.1007\/s00125-014-3278-9","relation":{},"ISSN":["0012-186X","1432-0428"],"issn-type":[{"value":"0012-186X","type":"print"},{"value":"1432-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,6,4]]}}}